Screener
Glaukos GKOS Research And Development In Process Expense
Research And Development In Process Expense at other companies
Other financials
Where this comes from
Reported directly by Glaukos in its filing.
Tagged under the XBRL concept gkos:ResearchAndDevelopmentInProcessExpense.
The source filing: Glaukos’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324201
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Selling, general and administrative | 116,060 | 83,375 | 209,003 | 154,048 |
| Research and development | 51,301 | 36,538 | 95,446 | 68,891 |
| Acquired in-process research and development | 1,500 | - | 1,500 | - |
| Total operating expenses | 168,861 | 119,913 | 305,949 | 222,939 |
| Loss from operations | (17,267) | (22,689) | (37,123) | (43,367) |
| Non-operating income (expense): | ||||
| Interest income | 2,279 | 2,574 | 4,710 | 5,650 |
Item 1. Financial Statements
FAQ
- What is Glaukos's research and development in process expense?
- Glaukos (GKOS) reported research and development in process expense of $1.5M in Q2 2026.
- What does research and development in process expense mean?
- This metric captures the specific costs associated with acquired research and development projects that have not yet reached technological feasibility. It is often a one-time charge related to the acquisition of intellectual property or early-stage pipeline assets.
Ask your AI about Glaukos's research and development in process expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude